*By Christian Smith* Ava, the medtech company that makes wristbands for women tracking their fertility, announced Wednesday that it raised $30 million in Series B funding, money its co-founder said would be used to continue the company's research. "Women's health and women's health research has been underfunded for the last decade," Lea von Bidder, Ava's co-founder, said in an interview with Cheddar. "We want to do a lot of research in different fields of women's health ー be it pregnancy monitoring, be it contraception, be it menopause ーand hope to give women insights about their body and health." Ava conducts its research through clinical trials with the University Hospital of Zurich, where the company was founded in 2014. Its wearable tracker is like a Fitbit for fertility, monitoring nine physiological metrics including heart and breathing rates, skin temperature, and heat loss to determine a woman's fertility cycle. Von Bidder said the company's research shows that the device is 89 percent accurate in predicting the 5.3 fertile days in a woman's cycle. In addition to the tracker, Ava also offers an app, which tracks a woman's health during her pregnancy. So far, 10,000 babies have been born to mothers using the Ava tracker, the company announced on Wednesday. Ava's founder said they want to offer contraception and family-planning products, too, but the company doesn't have a time frame for these types of products. "Ava at this point is not a contraceptive yet," von Bidden said. "We are working really hard on making that happen." For the full interview, [click here](https://cheddar.com/videos/fertility-tracking-company-ava-raises-30-million-in-series-b-funding-round).

Share:
More In Business
Walmart warns “higher prices are inevitable”
Walmart, which became the nation’s largest retailer by making low prices a priority, has found itself in a place it’s rarely been: Warning customers that prices will rise for goods ranging from bananas to car seats.
US businesses that rely on Chinese imports express relief and anxiety
American businesses that rely on Chinese goods are reacting with muted relief after the U.S. and China agreed to pause their exorbitant tariffs on each other’s products for 90 days. Many companies delayed or canceled orders after President Donald Trump last month put a 145% tariff on items made in China. Importers still face relatively high tariffs, however, as well as uncertainty over what will happen in the coming weeks and months. The temporary truce was announced as retailers and their suppliers are looking to finalize their plans and orders for the holiday shopping season. They’re concerned a mad scramble to get goods onto ships will lead to bottlenecks and increased shipping costs.
Load More